Sustained-release intravitreal liquid drug delivery using triamcinolone acetonide for cystoid macular edema in retinal vein occlusion

Ophthalmology

Volumn 118, Issue 7, 2011, Pages 1416-1422

  Lim, Jennifer I ^a   Fung, Anne E ^b   Wieland, Mark ^c   Hung, Dean ^d   Wong, Vernon ^d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Pacific Eye Associates   (United States)

^c RETINA VITREOUS ASSOCIATES MEDICAL GROUP   (United States)

^d Icon Bioscience   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IBI 20089; TIMOLOL; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CATARACT; CENTRAL RETINA VEIN OCCLUSION; CHRONIC DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CONJUNCTIVAL HEMORRHAGE; CONTROLLED STUDY; DRUG DOSE ESCALATION; DRUG DOSE SEQUENCE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAOCULAR PRESSURE; IRIS DISEASE; LABORATORY TEST; LASER COAGULATION; MALE; MULTICENTER STUDY; NEOVASCULAR GLAUCOMA; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PHASE 1 CLINICAL TRIAL; PHYSICAL EXAMINATION; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RETINA MACULA CYSTOID EDEMA; RETINA NEOVASCULARIZATION; RETINA VEIN OCCLUSION; SIDE EFFECT; SLIT LAMP; SUSTAINED RELEASE FORMULATION; SUSTAINED RELEASE PREPARATION; VISION TEST; VISUAL ACUITY; VITREOUS HEMORRHAGE;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOCINOLONE ACETONIDE; FUNDUS OCULI; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE;

EID: 79959998734     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2010.12.029     Document Type: Article

References (7)

1. G.N. Scholes, W.J. O'Brien, G.W. Abrams, and M.F. Kubicek Clearance of triamcinolone from vitreous Arch Ophthalmol 103 1985 1567 1569 (Pubitemid 15240750)
2. H.S. Chin, T.S. Park, Y.S. Moon, and J.H. Oh Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes Retina 25 2005 556 560
3. SCORE Study Research Group A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5 Arch Ophthalmol 127 2009 1101 1114
4. J.A. Haller, F. Bandello, R. Belfort Jr OZURDEX GENEVA Study Group Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion Ophthalmology 117 2010 1134 1146
5. P.A. Campochiaro, G. Hafiz, and S.M. Shah Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator Mol Ther 16 2008 791 799 (Pubitemid 351426182)
6. P.A. Campochiaro, J.S. Heier, L. Feiner BRAVO Investigators Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary endpoint results of a phase III study Ophthalmology 117 2010 1102 1112
7. D.M. Brown, P.A. Campochiaro, R.P. Singh CRUISE Investigators Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1124 1133